Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Success and Predictability of Provox Prosthesis Voice Rehabilitation

Success and Predictability of Provox Prosthesis Voice Rehabilitation ObjectivesTo determine the success rate and relating clinical factors of voice prosthesis rehabilitation and to analyze the discrimination ability of the multidimensional Harrison–Robillard-Shultz Tracheoesophageal Puncture Rating Scale (HRS Rating Scale).DesignProspective clinical study.SettingUniversity Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Inselspital, Bern, Switzerland.Subjects And MethodsFrom 1992 through 1998, 87 patients with advanced squamous cell carcinoma of the larynx and/or hypopharynx underwent primary tracheoesophageal puncture after total laryngectomy. Clinician otolaryngologists and speech/language pathologists independently used the HRS Rating Scale for success assessment of voice prosthesis rehabilitation.ResultsAge, sex, tumor localization, tumor stage, and radiation therapy had no influence on the success of voice prosthesis rehabilitation. Overall, voice rehabilitation success rates between 40% and 62% were achieved. Speech/language pathologists and clinician otolaryngologists evaluated the same patient group without significant statistical differences. The HRS Rating Scale analysis showed an equal distribution of the subscale parameter carein functional and nonfunctional speakers and a strong correlation between the subscale parameters qualityand use.ConclusionsBecause of its safety and simplicity, tracheoesophageal puncture has become a state of the art method for voice rehabilitation after total laryngectomy. The short-term superiority of voice prosthesis in voice rehabilitation over esophageal speech rehabilitation must be seen in light of comparable long-term success rates of the 2 methods.THE LOSS of vocal function is generally considered the most disabling consequence of total laryngectomy. Many innovative surgical and nonsurgical procedures aim to restore the patient's verbal communication. Since the introduction of the first real tracheoesophageal valve prosthesis by Mozolewski in 1972, tracheoesophageal shunt techniques gained increasing acceptance because of the relative simplicity of the operation, the acquisition of speech, and better voice quality.Maves and Lingemanfirst described performing the primary tracheoesophageal puncture (TEP) at the time of laryngectomy. More than a dozen shunt valve prostheses were developed in the last 30 years.With reported success rates ranging from 50% to 90%, the results of surgical rehabilitation by means of voice prostheses are, on the average, better than rehabilitation by esophageal speech, with a success rate of 33%.The wide variability of reported success rates of the TEP procedure may be explained by the lack of controlled success criteria. Almost every published study used its own success criteria. In 1992, Harrison and Robillard-Shultz introduced the Harrison–Robillard-Shultz Tracheoesophageal Puncture Rating Scale (HRS Rating Scale), a 15-point rating scale incorporating key elements of the definitions of use and quality of speech as well as ability to care for the fistula and the prosthesis from 15 reviewed studies.Between 1992 and 1998, we consequently applied the HRS Rating Scale to our laryngectomized and voice prostheses–implanted patients. The purposes of the present study are to determine the success rate and relating clinical factors of voice prosthesis rehabilitation and to analyze the discrimination ability of the multidimensional HRS Rating Scale.PATIENTS AND METHODSPATIENTSBetween 1992 and 1998, 87 consecutive patients were primarily implanted with a Provox or Provox 2 (Atos Medical AB, Hörby, Sweden) voice prosthesis directly after total laryngectomy.This group consisted of 82 men and 5 women who ranged in age from 44 to 81 years, with a mean age of 62 years.Before total laryngectomy, patients underwent psychological evaluation and had the opportunity to speak to voice-rehabilitated patients. Patients with anticoagulation and diseases or anomalies prone to putative prosthesis handling problems, such as Parkinson disease, were not considered for voice prosthesis implantation. Each patient received voice prosthesis rehabilitation training by speech/language pathologists 14 days after laryngectomy. The speech/language pathologists observed the patients for about 18 months and during this time assessed their condition using the HRS Rating Scale after 2, 6, 12, and 18 months. The otolaryngologist checked the patients when the voice prosthesis had to be changed, mostly owing to leakage. Before the prosthesis was removed, the patient's condition was scored using the HRS Rating Scale. All patients were independently seen by the speech/language pathologist and otolaryngologist.Three rehabilitation times of voice prosthesis follow-up were arbitrarily defined: phase I covered months 0 through 9 after implantation; phase II, months 10 through 30; and phase III, months 31 through 72. Speech/language pathologists saw patients only in phases I and II, otolaryngologists in phases I, II, and III. According to the above-mentioned voice prosthesis follow-up procedure, speech/language pathologists saw the patients most often in phase I, while otolaryngologists compiled the most data in phase II. Moreover, all patients were seen in a tumor follow-up program every 1 to 3 months after the end of the surgical treatment and/or radiotherapy.For statistical analysis, the Mantel-Haenszel χ2test was used. For every patient, all ratings were summarized in a 2 × 2 cross-classification table, rater by ratings. The Mantel-Haenszel χ2test was used in all these tables to analyze the relation between rater and ratings. An unequal number of ratings from the speech/language pathologists and from the otolarnygologists were allowed.THE HRS RATING SCALEThe HRS Rating Scale(Figure 1) defined success by the following 3 parameters: (1) use(degree to which tracheoesophageal speech is used as the main means of communication), (2) quality(the ease of voice production and its effect on intelligibility), and (3) care(the patients' independence from professional aid for maintenance of the fistula and the prosthesis). Each parameter was scored on a 1- to 5-point scale. The score of 1 or 2 was considered nonfunctional; a score of 3, marginally functional; and a score of 4 or 5, functional. The 3 scores for the subscale parameters use, quality, and carewere then tallied for an overall score that ranged from 3 to 15. A total overall score of 12 or higher was established as the cutoff level for successful voice prosthesis rehabilitation.Because the Provox voice prosthesis was not to be self-removed and inserted by most patients, the maximum reachable score of the subscale parameter carein these patients was only 4 instead of 5 points. Either way, the cutoff level of 12 or more points for a functional speaker was maintained.Figure 1.The Harrison–Robillard-Shultz Tracheoesophageal Puncture (TEP) Rating Scale.The study used 2 approaches for success assessment: (1) patient independent, ie, every prosthesis was scored according to the above-mentioned criteria and cutoff level and (2) all prostheses used in every single patient were scored according to the above-mentioned criteria and cutoff level. A successful patient voice rehabilitation was defined as successful voice prosthesis rehabilitation in more than 50% of the assessed prostheses.RESULTSCLINICAL RESULTSTotal laryngectomy was indicated in 30 (34%) cases due to hypopharynx carcinoma and in 57 (66%) cases due to carcinoma of the larynx. Of the 87 patients in the sample, 8 (9%) had relapsing T2 tumors, 32 (37%) had T3, and 47 (54%) had T4. The N stage distribution included 49 patients (56%) with N0 lymph node status, 11 (13%) with N1, 25 (29%) with N2, and 2 (2%) with N3. While larynx carcinomas had N0 lymph node status in 64 patients (74%), hypopharynx carcinomas had N2 lymph node status in 59 patients (68%). Sixty-six patients (76%) received radiotherapy treatment. The Kaplan-Meier survival curve is shown in Figure 2. The 2-year survival rate of all patients was 70%, and the 5-year survival rate was 48%. Patients with hypopharynx carcinoma with N2 or N3 lymph node metastasis showed the worst prognoses.Figure 2.Kaplan-Meier proportion of survival curve with confidence intervals of 87 patients with advanced larynx and/or hypopharyx squamous cell carcinoma after laryngectomy.VOICE PROSTHESIS REHABILITATION RESULTSBased on the independent evaluation of speech/language pathologists and otolaryngologists, age, sex, tumor localization, tumor stage, and radiotherapy had no significant influence on the success of voice prosthesis rehabilitation. In phase I, the mean voice prosthesis life cycle was 4.2 months (2.14 prostheses in 9 months; 95% confidence interval, 1.55-2.74 prostheses) for successfully rehabilitated patients and 3.6 months (2.5 voice prostheses in 9 months; 95% confidence interval, 1.09-3.91 prostheses) for unsuccessfully rehabilitated patients. In phase II, successfully rehabilitated patients had significantly shorter voice prosthesis life cycles than unsuccessfully rehabilitated patients. The cost to the patient per year after successful voice rehabilitation is estimated to be about $600 (Euro $640). Medical complications of voice prosthesis rehabilitation were scarce and showed no correlation with voice rehabilitation success: 1 patient experienced aspiration, 2 patients ingested the Provox prosthesis, 3 patients had aspiration pneumonias due to periprosthetic leakage, and peristomal infections occurred in 4 patients and fistula granulomas in 2 patients. No patient died from a complication or resulting treatment. Inner prosthesis seepage was not considered to be a complication but a normal wear effect. Periprosthetic leakage was observed mostly in the old Provox prosthesis. Spontaneous closure of the tracheoesophageal fistula with prosthesis in place occurred in 14 patients (8 functional and 6 nonfunctional speakers). Five functional and 1 nonfunctional speakers asked for insertion of a new prosthesis. Of the other 8 patients, 5 were nonfunctional speakers; the 3 functional speakers had learned esophageal speech in parallel and did not want a new voice prosthesis inserted.EVALUATION BY SPEECH/LANGUAGE PATHOLOGISTThe 87 patients were seen 218 times by speech/language pathologists; 38 patients were seen only in phase I and 49 patients in phases I and II. Phase I includes 160 HRS Rating Scale assessments and phase II includes 58. The results of voice prosthesisassessments are given in Table 1. Speech/language pathologists observed a successful voice prosthesis rehabilitation for 34% of all voice prosthesis assessments in phase I, 64% in phase II, and 42% in both phases. The overall and corresponding phase I-II results of speech/language pathologist patientassessments are given in Table 2. Speech/language pathologists found that 29% of the individual patients showed a successful voice prosthesis rehabilitation in phase I, 65% in phase II, and 40% in phases I and II.Table 1. Voice Prosthesis Success Rates*Phase IPhase IIPhase IIIOverallSpeech/language pathologist34 (55/160)64 (37/58)NA42 (92/218)Otolaryngologist39 (69/176)77 (136/177)81 (58/72)62 (263/425)*Data are percentage of successful Harrison−Robillard-Schultz Rating Scale assessments (number of successful assessments/total number). NA indicates not applicable.Table 2. Patient Success Rates*Phase IPhase IIPhase IIIOverallSpeech/language pathologist11 (29)32 (65)NA43 (40)Otolaryngologist17 (34)15 (68)11 (73)43 (54)*Data are number (percentage) of successful voice prostheses rehabilitation in patients. NA indicates not applicable.EVALUATION BY OTOLARYNGOLOGISTThe 87 patients were seen 425 times by otolaryngologists; 50 patients were seen only in phase I, 22 patients in phases I and II, and 15 patients in phase I, II, and III. Phase I includes 176 HRS Rating Scale assessments; phase II, 177; and phase III, 72. The overall and corresponding phase I-II results of otolaryngologist voice prosthesisassessments are given in Table 1. Otolaryngologists observed a successful voice prosthesis rehabilitation for 39% of all voice prosthesis assessments in phase I, 77% in phase II, 81% in phase III, and 62% in all phases. The overall and corresponding phase I-II results of otolaryngologist patientassessments are given in Table 2. A successful voice prosthesis rehabilitation was seen for 34% of the individual patients in phase I, 68% in phase II, 73% in phase III (not given in Table 2), and 54% in all phases,.The Mantel-Haenszel χ2tests comparing all data for each patient independently revealed no significant difference in HRS Rating Scale success assessments by speech/language pathologists and otolaryngologists (phase I, P= .29; phase II, P= .81). The Pvalues are far from significant, so there is no hint of a difference in ratings between speech/language pathologists and otolaryngologists for phase I, with ratings of 87 patients, and even for phase II, with ratings of only 37 patients. According to their higher voice prosthesis replacement frequency, patients with successful voice rehabilitation were seen more often by otolaryngologists. The success rate of phase II was statistically significantly higher than phase I in speech/language pathologist and otolaryngologist assessments (P= .003), and the success rate of phase III (assessed only by otolaryngologists) was statistically significantly higher than phase II (P= .02).HRS RATING SCALETable 3gives the rating scale distribution for the 3 HRS Rating Scale criteria use, quality, and carefor speech/language pathologists and otolaryngologists. The criterion careshows a much narrower distribution for both assessors, resulting in a much lower standard deviation than the criteria qualityand use.Table 3. Rating Scale Distribution for the HRS Rating Scale Criteria Use, Quality, and Care*HRS Rating Scale Score†UseQualityCareOLSLPOLSLPOLSLP117.230.314.619.903.2211.322.08.223.110.85.538.26.98.58.39.26.9454.539.031.518.174.181.258.91.837.230.65.93.2*Data are percentage of assessments by otolaryngologists (OL) or speech/language pathologists (SLP) as specified.†Harrison−Robillard-Schultz (HRS) Rating Scale scores 1 to 5 represent the subscore for each criterion.Table 4correlates the successful and nonsuccessful event status based on the 3 criteria quality, use, and careto the rating scale sum distribution of 2 criteria: choosing a cutoff line between 7 and 8 points for an evaluation of success seemed to be the most appropriate approach. The contribution of the criterion careto an evaluation of success is minimal owing to the uniform rating scale distribution. Eliminating the subscale parameter carewould have changed the success status in 0 of 425 prostheses assessed by otolaryngologists and in 1 of 217 prostheses assessed by speech/language pathologists.Table 4. Correlation of Voice Prosthesis Rehabilitation Success Status Based on 3 Criteria to the Rating Scale Subscore Distribution of 2 HRS Criteria*HRS Rating Scale Score†Use/QualityQuality/CareCare/UseOLSLPOLSLPOLSLP+−+−+−+−+−+−1000100000000205904300060006301402003709039010402103002508025012501608020035027045603201702103703803870201603601622769810003309823261220467959132050401470642510701031040180206000*Data are number of 3 HRS criteria–based successful (+) or nonsuccessful (−) event status assessments by otolaryngologists (OL) or speech/language pathologists (SPL) as specified.†Harrison−Robillard-Schultz (HRS) Rating Scale scores 1 through 10 represent the combined subscore of 2 of 3 criteria.The criteria useand qualitycorrelate strongly. For both otolaryngologists and speech/language pathologists, the Spearman rank correlation between use and quality is higher (correlation factor, 0.8 [otolaryngologists] and 0.87 [speech/language pathologists]) than between use and care (correlation factor, 0.66 and 0.43, respectively) and between quality and care (correlation factor, 0.64 and 0.42, respectively). Lacking either one of the criteria useand qualitydoes not significantly change the evaluation of a successful voice prosthesis rehabilitation.COMMENTOver the past 2 decades, TEP has grown to become a state of-the-art method for voice rehabilitation after total laryngectomy. In contrast to esophagus speech rehabilitation, TEP allowed patients speech and clear communication already by the fifth postoperative week after laryngectomy.The safety and simplicity of the surgical and follow-up procedure are confirmed by our data. Handling of the fistula and prosthesis can be learned well and often turns the motivated patient into a voice prosthesis expert. A prosthesis life cycle of about 4 months can be expected in successfully rehabilitated long-term patients. In our population, an in situ longevity of 10 or more months as described by Laccourreye et alwas exceptional and mostly observed in unsuccessfully rehabilitated patients.As in other mechanical valves, use-induced wear may shorten voice prosthesis longevity. In several patients, a suddenly decreasing voice quality in functional speakers was correlated with local or metastatic tumor relapse.The HRS Rating Scale was applied without problems by the 2 independent tester groups. No differences were observed in the results. The cutoff level proposed by Harrison and Robillard-Shultz is observed to be correct. Due to a narrow distribution in our patient group, the subscale parameter caredid not really contribute to the evaluation of success of voice prosthesis rehabilitation. The excellent prosthesis handling and care attitude in our population could be a local geographical phenomenon. Also, the almost identical distribution of the subscale parameters useand qualitymay be attributed to our study group. More data are needed to evaluate the validity of the individual subscale parameters.Success rates for voice prosthesis rehabilitation vary from 50% to 90% in the literature. The success variety may be explained by a bonus factor for the new method, a heterogeneous patient population, and a different and deficient evaluation system.The present study is the first to have applied the published multiparametric voice prosthesis HRS Rating Scale to TEP evaluation.The same approach is used by 2 independent tester groups. Moreover, the rated success is correlated with the individual patient and with the single prosthesis. Speech/language pathologists and otolaryngologists evaluated the same patient group without statistically significant differences. The overall patientsuccess rates of our assessment groups are 40% (speech/language pathologists) and 54% (otolaryngologists), and the overall voice prosthesissuccess rates are 42% (speech/language pathologists) and 62% (otolaryngologists). Short-term success reports dominated the studies of the 1980s. Interestingly, in the literature, the long-term success is slightly lower than the short-term success. We observed no such decrease but instead found a learning curve with an increase of success over time. This complies with a shorter voice prosthesis longevity in the advanced functional speaker compared with the beginner. The 50% overall success rate of voice prosthesis rehabilitation is not far removed from the 33% success rate of esophageal speech rehabilitation, the classic long-term approach for voice rehabilitation.However, 24% of functional speakers with spontaneous closure of the fistula renounced a new prosthesis implant and preferred esophageal speech rehabilitation of "less hassle." Their esophageal speech abilities developed in parallel to voice prosthesis rehabilitation.In our estimation, voice prosthesis rehabilitation is the essential first step in voice rehabilitation after total laryngectomy. A functionally rehabilitated voice prosthesis speaker may more easily switch to esophageal speech. A special effort is required on the part of the speech/language pathologist to perform both the TEP as well as the esophageal speech rehabilitation.RVan WeissenbruchFWJAlbersVoice rehabilitation after total laryngectomy.Acta Otorhinolaryngol Belg.1992;46:221-246.MDMavesRELingemanPrimary vocal rehabilitation using the Blom-Singer and Panje voice prosthesis.Ann Otol Rhinol Laryngol.1982;91:458-460.JRShultzJHarrisonDefining and predicting tracheoesophageal puncture success.Arch Otolaryngol Head Neck Surg.1992;118:811-816.FJMHilgersPFSchouwenburgA new low-resistance, self-retaining prosthesis (Provox) for voice rehabilitation after total laryngectomy.Laryngoscope.1990;100:1202-1207.FJHilgersAHAckerstaffAJBalmIBTanNKAaronsonJOPerssonDevelopment and clinical evaluation of a second-generation voice prosthesis designed for anterograde and retrograde insertion.Acta Otolaryngol.1997;117:889-896.RVan WeissenbruchFWAlbersVoice rehabilitation after total laryngectomy using the Provox voice prosthesis.Clin Otolaryngol.1993;18:359-364.OLaccourreyeMMenardLCrevier-BuchmanVCouloignerDBrasnuIn situ lifetime, causes for replacement, and complications of the Provox voice prosthesis.Laryngoscope.1997;107:527-530.JPDe CarpentierWDRyderSRSaeedTJWoolfordSurvival times of Provox valves.J Laryngol Otol.1996;110:37-42.SJWetmoreKKruegerKWessonMBlessingLong term results of the Blom-Singer speech rehabilitation procedure.Arch Otolaryngol.1985;111:106-109.SHWWongAPWYuenCCheungWIWeiLKLamLong-term results of voice rehabilitation after total laryngectomy using primary tracheoesophageal puncture in Chinese patients.Am J Otolaryngol.1997;18:94-98.JAGeraghtyBESmithBLWeinigLGPortugalLong-term follow-up of tracheoesophageal puncture results.Ann Otol Rhinol Laryngol.1996;105:501-503.ARMehtaSSarkarSAMehtaGKBachherThe Indian experience with immediate tracheoesophageal puncture for voice restoration.Eur Arch Otorhinolaryngol.1995;252:209-214.WWKaoRMMohrCAKimmelCGetchCSilvermanThe outcome and techniques of primary and secondary tracheoesophageal puncture.Arch Otolaryngol Head Neck Surg.1994;120:301-307.Hde MaddalenaMMaassenRAroldMPtokHPZennerStimmrehabilitation nach Laryngektomie mit Stimmprothesen: Ergebnisse einer prospektiven Verlaufsuntersuchung.Laryngorhinootologie.1992;71:416-422.JLSt GuilyBAngelardMEl-BezPostlaryngectomy voice restoration.Arch Otolaryngol Head Neck Surg.1992;118:252-255.CAMilfordARPerryTAMuglistonADCheesmanA British experience of surgical voice restoration as a primary procedure.Arch Otolaryngol Head Neck Surg.1988;114:1419-1421.WFLauWIWeiCMHoKHLamImmediate tracheoesophageal puncture for voice restoration in laryngopharyngeal resection.Am J Surg.1988;156:269-272.RCHamakerMISingerEDBlomHADanielsPrimary voice restoration at laryngectomy.Arch Otolaryngol.1985;111:182-186.JMHeatonDSandersonIRDunsmoreAJParkerSpeech assessment of patients using three types of indwelling tracheo-oesophageal voice prosthesis.J Laryngol Otol.1996;110:343-347.ECantuWJRyanSTanseyCSJohnsonTracheoesophageal speech: predictors of success and social validity ratings.Am J Otolaryngol.1998;19:12-17.Accepted for publication November 2, 2001.This article was presented in part at the 107th Congrès Français d'Otorhinolaryngologie et de Pathologie Cervico-faciale, Paris, France, October 1-3, 2000.Corresponding author and reprints: Michel A. Hotz, MD, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Inselspital, 3010 Bern, Switzerland (e-mail: michael.hotz@insel.ch). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Success and Predictability of Provox Prosthesis Voice Rehabilitation

Loading next page...
 
/lp/american-medical-association/success-and-predictability-of-provox-prosthesis-voice-rehabilitation-EnmxqOidwV
Publisher
American Medical Association
Copyright
Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/archotol.128.6.687
Publisher site
See Article on Publisher Site

Abstract

ObjectivesTo determine the success rate and relating clinical factors of voice prosthesis rehabilitation and to analyze the discrimination ability of the multidimensional Harrison–Robillard-Shultz Tracheoesophageal Puncture Rating Scale (HRS Rating Scale).DesignProspective clinical study.SettingUniversity Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Inselspital, Bern, Switzerland.Subjects And MethodsFrom 1992 through 1998, 87 patients with advanced squamous cell carcinoma of the larynx and/or hypopharynx underwent primary tracheoesophageal puncture after total laryngectomy. Clinician otolaryngologists and speech/language pathologists independently used the HRS Rating Scale for success assessment of voice prosthesis rehabilitation.ResultsAge, sex, tumor localization, tumor stage, and radiation therapy had no influence on the success of voice prosthesis rehabilitation. Overall, voice rehabilitation success rates between 40% and 62% were achieved. Speech/language pathologists and clinician otolaryngologists evaluated the same patient group without significant statistical differences. The HRS Rating Scale analysis showed an equal distribution of the subscale parameter carein functional and nonfunctional speakers and a strong correlation between the subscale parameters qualityand use.ConclusionsBecause of its safety and simplicity, tracheoesophageal puncture has become a state of the art method for voice rehabilitation after total laryngectomy. The short-term superiority of voice prosthesis in voice rehabilitation over esophageal speech rehabilitation must be seen in light of comparable long-term success rates of the 2 methods.THE LOSS of vocal function is generally considered the most disabling consequence of total laryngectomy. Many innovative surgical and nonsurgical procedures aim to restore the patient's verbal communication. Since the introduction of the first real tracheoesophageal valve prosthesis by Mozolewski in 1972, tracheoesophageal shunt techniques gained increasing acceptance because of the relative simplicity of the operation, the acquisition of speech, and better voice quality.Maves and Lingemanfirst described performing the primary tracheoesophageal puncture (TEP) at the time of laryngectomy. More than a dozen shunt valve prostheses were developed in the last 30 years.With reported success rates ranging from 50% to 90%, the results of surgical rehabilitation by means of voice prostheses are, on the average, better than rehabilitation by esophageal speech, with a success rate of 33%.The wide variability of reported success rates of the TEP procedure may be explained by the lack of controlled success criteria. Almost every published study used its own success criteria. In 1992, Harrison and Robillard-Shultz introduced the Harrison–Robillard-Shultz Tracheoesophageal Puncture Rating Scale (HRS Rating Scale), a 15-point rating scale incorporating key elements of the definitions of use and quality of speech as well as ability to care for the fistula and the prosthesis from 15 reviewed studies.Between 1992 and 1998, we consequently applied the HRS Rating Scale to our laryngectomized and voice prostheses–implanted patients. The purposes of the present study are to determine the success rate and relating clinical factors of voice prosthesis rehabilitation and to analyze the discrimination ability of the multidimensional HRS Rating Scale.PATIENTS AND METHODSPATIENTSBetween 1992 and 1998, 87 consecutive patients were primarily implanted with a Provox or Provox 2 (Atos Medical AB, Hörby, Sweden) voice prosthesis directly after total laryngectomy.This group consisted of 82 men and 5 women who ranged in age from 44 to 81 years, with a mean age of 62 years.Before total laryngectomy, patients underwent psychological evaluation and had the opportunity to speak to voice-rehabilitated patients. Patients with anticoagulation and diseases or anomalies prone to putative prosthesis handling problems, such as Parkinson disease, were not considered for voice prosthesis implantation. Each patient received voice prosthesis rehabilitation training by speech/language pathologists 14 days after laryngectomy. The speech/language pathologists observed the patients for about 18 months and during this time assessed their condition using the HRS Rating Scale after 2, 6, 12, and 18 months. The otolaryngologist checked the patients when the voice prosthesis had to be changed, mostly owing to leakage. Before the prosthesis was removed, the patient's condition was scored using the HRS Rating Scale. All patients were independently seen by the speech/language pathologist and otolaryngologist.Three rehabilitation times of voice prosthesis follow-up were arbitrarily defined: phase I covered months 0 through 9 after implantation; phase II, months 10 through 30; and phase III, months 31 through 72. Speech/language pathologists saw patients only in phases I and II, otolaryngologists in phases I, II, and III. According to the above-mentioned voice prosthesis follow-up procedure, speech/language pathologists saw the patients most often in phase I, while otolaryngologists compiled the most data in phase II. Moreover, all patients were seen in a tumor follow-up program every 1 to 3 months after the end of the surgical treatment and/or radiotherapy.For statistical analysis, the Mantel-Haenszel χ2test was used. For every patient, all ratings were summarized in a 2 × 2 cross-classification table, rater by ratings. The Mantel-Haenszel χ2test was used in all these tables to analyze the relation between rater and ratings. An unequal number of ratings from the speech/language pathologists and from the otolarnygologists were allowed.THE HRS RATING SCALEThe HRS Rating Scale(Figure 1) defined success by the following 3 parameters: (1) use(degree to which tracheoesophageal speech is used as the main means of communication), (2) quality(the ease of voice production and its effect on intelligibility), and (3) care(the patients' independence from professional aid for maintenance of the fistula and the prosthesis). Each parameter was scored on a 1- to 5-point scale. The score of 1 or 2 was considered nonfunctional; a score of 3, marginally functional; and a score of 4 or 5, functional. The 3 scores for the subscale parameters use, quality, and carewere then tallied for an overall score that ranged from 3 to 15. A total overall score of 12 or higher was established as the cutoff level for successful voice prosthesis rehabilitation.Because the Provox voice prosthesis was not to be self-removed and inserted by most patients, the maximum reachable score of the subscale parameter carein these patients was only 4 instead of 5 points. Either way, the cutoff level of 12 or more points for a functional speaker was maintained.Figure 1.The Harrison–Robillard-Shultz Tracheoesophageal Puncture (TEP) Rating Scale.The study used 2 approaches for success assessment: (1) patient independent, ie, every prosthesis was scored according to the above-mentioned criteria and cutoff level and (2) all prostheses used in every single patient were scored according to the above-mentioned criteria and cutoff level. A successful patient voice rehabilitation was defined as successful voice prosthesis rehabilitation in more than 50% of the assessed prostheses.RESULTSCLINICAL RESULTSTotal laryngectomy was indicated in 30 (34%) cases due to hypopharynx carcinoma and in 57 (66%) cases due to carcinoma of the larynx. Of the 87 patients in the sample, 8 (9%) had relapsing T2 tumors, 32 (37%) had T3, and 47 (54%) had T4. The N stage distribution included 49 patients (56%) with N0 lymph node status, 11 (13%) with N1, 25 (29%) with N2, and 2 (2%) with N3. While larynx carcinomas had N0 lymph node status in 64 patients (74%), hypopharynx carcinomas had N2 lymph node status in 59 patients (68%). Sixty-six patients (76%) received radiotherapy treatment. The Kaplan-Meier survival curve is shown in Figure 2. The 2-year survival rate of all patients was 70%, and the 5-year survival rate was 48%. Patients with hypopharynx carcinoma with N2 or N3 lymph node metastasis showed the worst prognoses.Figure 2.Kaplan-Meier proportion of survival curve with confidence intervals of 87 patients with advanced larynx and/or hypopharyx squamous cell carcinoma after laryngectomy.VOICE PROSTHESIS REHABILITATION RESULTSBased on the independent evaluation of speech/language pathologists and otolaryngologists, age, sex, tumor localization, tumor stage, and radiotherapy had no significant influence on the success of voice prosthesis rehabilitation. In phase I, the mean voice prosthesis life cycle was 4.2 months (2.14 prostheses in 9 months; 95% confidence interval, 1.55-2.74 prostheses) for successfully rehabilitated patients and 3.6 months (2.5 voice prostheses in 9 months; 95% confidence interval, 1.09-3.91 prostheses) for unsuccessfully rehabilitated patients. In phase II, successfully rehabilitated patients had significantly shorter voice prosthesis life cycles than unsuccessfully rehabilitated patients. The cost to the patient per year after successful voice rehabilitation is estimated to be about $600 (Euro $640). Medical complications of voice prosthesis rehabilitation were scarce and showed no correlation with voice rehabilitation success: 1 patient experienced aspiration, 2 patients ingested the Provox prosthesis, 3 patients had aspiration pneumonias due to periprosthetic leakage, and peristomal infections occurred in 4 patients and fistula granulomas in 2 patients. No patient died from a complication or resulting treatment. Inner prosthesis seepage was not considered to be a complication but a normal wear effect. Periprosthetic leakage was observed mostly in the old Provox prosthesis. Spontaneous closure of the tracheoesophageal fistula with prosthesis in place occurred in 14 patients (8 functional and 6 nonfunctional speakers). Five functional and 1 nonfunctional speakers asked for insertion of a new prosthesis. Of the other 8 patients, 5 were nonfunctional speakers; the 3 functional speakers had learned esophageal speech in parallel and did not want a new voice prosthesis inserted.EVALUATION BY SPEECH/LANGUAGE PATHOLOGISTThe 87 patients were seen 218 times by speech/language pathologists; 38 patients were seen only in phase I and 49 patients in phases I and II. Phase I includes 160 HRS Rating Scale assessments and phase II includes 58. The results of voice prosthesisassessments are given in Table 1. Speech/language pathologists observed a successful voice prosthesis rehabilitation for 34% of all voice prosthesis assessments in phase I, 64% in phase II, and 42% in both phases. The overall and corresponding phase I-II results of speech/language pathologist patientassessments are given in Table 2. Speech/language pathologists found that 29% of the individual patients showed a successful voice prosthesis rehabilitation in phase I, 65% in phase II, and 40% in phases I and II.Table 1. Voice Prosthesis Success Rates*Phase IPhase IIPhase IIIOverallSpeech/language pathologist34 (55/160)64 (37/58)NA42 (92/218)Otolaryngologist39 (69/176)77 (136/177)81 (58/72)62 (263/425)*Data are percentage of successful Harrison−Robillard-Schultz Rating Scale assessments (number of successful assessments/total number). NA indicates not applicable.Table 2. Patient Success Rates*Phase IPhase IIPhase IIIOverallSpeech/language pathologist11 (29)32 (65)NA43 (40)Otolaryngologist17 (34)15 (68)11 (73)43 (54)*Data are number (percentage) of successful voice prostheses rehabilitation in patients. NA indicates not applicable.EVALUATION BY OTOLARYNGOLOGISTThe 87 patients were seen 425 times by otolaryngologists; 50 patients were seen only in phase I, 22 patients in phases I and II, and 15 patients in phase I, II, and III. Phase I includes 176 HRS Rating Scale assessments; phase II, 177; and phase III, 72. The overall and corresponding phase I-II results of otolaryngologist voice prosthesisassessments are given in Table 1. Otolaryngologists observed a successful voice prosthesis rehabilitation for 39% of all voice prosthesis assessments in phase I, 77% in phase II, 81% in phase III, and 62% in all phases. The overall and corresponding phase I-II results of otolaryngologist patientassessments are given in Table 2. A successful voice prosthesis rehabilitation was seen for 34% of the individual patients in phase I, 68% in phase II, 73% in phase III (not given in Table 2), and 54% in all phases,.The Mantel-Haenszel χ2tests comparing all data for each patient independently revealed no significant difference in HRS Rating Scale success assessments by speech/language pathologists and otolaryngologists (phase I, P= .29; phase II, P= .81). The Pvalues are far from significant, so there is no hint of a difference in ratings between speech/language pathologists and otolaryngologists for phase I, with ratings of 87 patients, and even for phase II, with ratings of only 37 patients. According to their higher voice prosthesis replacement frequency, patients with successful voice rehabilitation were seen more often by otolaryngologists. The success rate of phase II was statistically significantly higher than phase I in speech/language pathologist and otolaryngologist assessments (P= .003), and the success rate of phase III (assessed only by otolaryngologists) was statistically significantly higher than phase II (P= .02).HRS RATING SCALETable 3gives the rating scale distribution for the 3 HRS Rating Scale criteria use, quality, and carefor speech/language pathologists and otolaryngologists. The criterion careshows a much narrower distribution for both assessors, resulting in a much lower standard deviation than the criteria qualityand use.Table 3. Rating Scale Distribution for the HRS Rating Scale Criteria Use, Quality, and Care*HRS Rating Scale Score†UseQualityCareOLSLPOLSLPOLSLP117.230.314.619.903.2211.322.08.223.110.85.538.26.98.58.39.26.9454.539.031.518.174.181.258.91.837.230.65.93.2*Data are percentage of assessments by otolaryngologists (OL) or speech/language pathologists (SLP) as specified.†Harrison−Robillard-Schultz (HRS) Rating Scale scores 1 to 5 represent the subscore for each criterion.Table 4correlates the successful and nonsuccessful event status based on the 3 criteria quality, use, and careto the rating scale sum distribution of 2 criteria: choosing a cutoff line between 7 and 8 points for an evaluation of success seemed to be the most appropriate approach. The contribution of the criterion careto an evaluation of success is minimal owing to the uniform rating scale distribution. Eliminating the subscale parameter carewould have changed the success status in 0 of 425 prostheses assessed by otolaryngologists and in 1 of 217 prostheses assessed by speech/language pathologists.Table 4. Correlation of Voice Prosthesis Rehabilitation Success Status Based on 3 Criteria to the Rating Scale Subscore Distribution of 2 HRS Criteria*HRS Rating Scale Score†Use/QualityQuality/CareCare/UseOLSLPOLSLPOLSLP+−+−+−+−+−+−1000100000000205904300060006301402003709039010402103002508025012501608020035027045603201702103703803870201603601622769810003309823261220467959132050401470642510701031040180206000*Data are number of 3 HRS criteria–based successful (+) or nonsuccessful (−) event status assessments by otolaryngologists (OL) or speech/language pathologists (SPL) as specified.†Harrison−Robillard-Schultz (HRS) Rating Scale scores 1 through 10 represent the combined subscore of 2 of 3 criteria.The criteria useand qualitycorrelate strongly. For both otolaryngologists and speech/language pathologists, the Spearman rank correlation between use and quality is higher (correlation factor, 0.8 [otolaryngologists] and 0.87 [speech/language pathologists]) than between use and care (correlation factor, 0.66 and 0.43, respectively) and between quality and care (correlation factor, 0.64 and 0.42, respectively). Lacking either one of the criteria useand qualitydoes not significantly change the evaluation of a successful voice prosthesis rehabilitation.COMMENTOver the past 2 decades, TEP has grown to become a state of-the-art method for voice rehabilitation after total laryngectomy. In contrast to esophagus speech rehabilitation, TEP allowed patients speech and clear communication already by the fifth postoperative week after laryngectomy.The safety and simplicity of the surgical and follow-up procedure are confirmed by our data. Handling of the fistula and prosthesis can be learned well and often turns the motivated patient into a voice prosthesis expert. A prosthesis life cycle of about 4 months can be expected in successfully rehabilitated long-term patients. In our population, an in situ longevity of 10 or more months as described by Laccourreye et alwas exceptional and mostly observed in unsuccessfully rehabilitated patients.As in other mechanical valves, use-induced wear may shorten voice prosthesis longevity. In several patients, a suddenly decreasing voice quality in functional speakers was correlated with local or metastatic tumor relapse.The HRS Rating Scale was applied without problems by the 2 independent tester groups. No differences were observed in the results. The cutoff level proposed by Harrison and Robillard-Shultz is observed to be correct. Due to a narrow distribution in our patient group, the subscale parameter caredid not really contribute to the evaluation of success of voice prosthesis rehabilitation. The excellent prosthesis handling and care attitude in our population could be a local geographical phenomenon. Also, the almost identical distribution of the subscale parameters useand qualitymay be attributed to our study group. More data are needed to evaluate the validity of the individual subscale parameters.Success rates for voice prosthesis rehabilitation vary from 50% to 90% in the literature. The success variety may be explained by a bonus factor for the new method, a heterogeneous patient population, and a different and deficient evaluation system.The present study is the first to have applied the published multiparametric voice prosthesis HRS Rating Scale to TEP evaluation.The same approach is used by 2 independent tester groups. Moreover, the rated success is correlated with the individual patient and with the single prosthesis. Speech/language pathologists and otolaryngologists evaluated the same patient group without statistically significant differences. The overall patientsuccess rates of our assessment groups are 40% (speech/language pathologists) and 54% (otolaryngologists), and the overall voice prosthesissuccess rates are 42% (speech/language pathologists) and 62% (otolaryngologists). Short-term success reports dominated the studies of the 1980s. Interestingly, in the literature, the long-term success is slightly lower than the short-term success. We observed no such decrease but instead found a learning curve with an increase of success over time. This complies with a shorter voice prosthesis longevity in the advanced functional speaker compared with the beginner. The 50% overall success rate of voice prosthesis rehabilitation is not far removed from the 33% success rate of esophageal speech rehabilitation, the classic long-term approach for voice rehabilitation.However, 24% of functional speakers with spontaneous closure of the fistula renounced a new prosthesis implant and preferred esophageal speech rehabilitation of "less hassle." Their esophageal speech abilities developed in parallel to voice prosthesis rehabilitation.In our estimation, voice prosthesis rehabilitation is the essential first step in voice rehabilitation after total laryngectomy. A functionally rehabilitated voice prosthesis speaker may more easily switch to esophageal speech. A special effort is required on the part of the speech/language pathologist to perform both the TEP as well as the esophageal speech rehabilitation.RVan WeissenbruchFWJAlbersVoice rehabilitation after total laryngectomy.Acta Otorhinolaryngol Belg.1992;46:221-246.MDMavesRELingemanPrimary vocal rehabilitation using the Blom-Singer and Panje voice prosthesis.Ann Otol Rhinol Laryngol.1982;91:458-460.JRShultzJHarrisonDefining and predicting tracheoesophageal puncture success.Arch Otolaryngol Head Neck Surg.1992;118:811-816.FJMHilgersPFSchouwenburgA new low-resistance, self-retaining prosthesis (Provox) for voice rehabilitation after total laryngectomy.Laryngoscope.1990;100:1202-1207.FJHilgersAHAckerstaffAJBalmIBTanNKAaronsonJOPerssonDevelopment and clinical evaluation of a second-generation voice prosthesis designed for anterograde and retrograde insertion.Acta Otolaryngol.1997;117:889-896.RVan WeissenbruchFWAlbersVoice rehabilitation after total laryngectomy using the Provox voice prosthesis.Clin Otolaryngol.1993;18:359-364.OLaccourreyeMMenardLCrevier-BuchmanVCouloignerDBrasnuIn situ lifetime, causes for replacement, and complications of the Provox voice prosthesis.Laryngoscope.1997;107:527-530.JPDe CarpentierWDRyderSRSaeedTJWoolfordSurvival times of Provox valves.J Laryngol Otol.1996;110:37-42.SJWetmoreKKruegerKWessonMBlessingLong term results of the Blom-Singer speech rehabilitation procedure.Arch Otolaryngol.1985;111:106-109.SHWWongAPWYuenCCheungWIWeiLKLamLong-term results of voice rehabilitation after total laryngectomy using primary tracheoesophageal puncture in Chinese patients.Am J Otolaryngol.1997;18:94-98.JAGeraghtyBESmithBLWeinigLGPortugalLong-term follow-up of tracheoesophageal puncture results.Ann Otol Rhinol Laryngol.1996;105:501-503.ARMehtaSSarkarSAMehtaGKBachherThe Indian experience with immediate tracheoesophageal puncture for voice restoration.Eur Arch Otorhinolaryngol.1995;252:209-214.WWKaoRMMohrCAKimmelCGetchCSilvermanThe outcome and techniques of primary and secondary tracheoesophageal puncture.Arch Otolaryngol Head Neck Surg.1994;120:301-307.Hde MaddalenaMMaassenRAroldMPtokHPZennerStimmrehabilitation nach Laryngektomie mit Stimmprothesen: Ergebnisse einer prospektiven Verlaufsuntersuchung.Laryngorhinootologie.1992;71:416-422.JLSt GuilyBAngelardMEl-BezPostlaryngectomy voice restoration.Arch Otolaryngol Head Neck Surg.1992;118:252-255.CAMilfordARPerryTAMuglistonADCheesmanA British experience of surgical voice restoration as a primary procedure.Arch Otolaryngol Head Neck Surg.1988;114:1419-1421.WFLauWIWeiCMHoKHLamImmediate tracheoesophageal puncture for voice restoration in laryngopharyngeal resection.Am J Surg.1988;156:269-272.RCHamakerMISingerEDBlomHADanielsPrimary voice restoration at laryngectomy.Arch Otolaryngol.1985;111:182-186.JMHeatonDSandersonIRDunsmoreAJParkerSpeech assessment of patients using three types of indwelling tracheo-oesophageal voice prosthesis.J Laryngol Otol.1996;110:343-347.ECantuWJRyanSTanseyCSJohnsonTracheoesophageal speech: predictors of success and social validity ratings.Am J Otolaryngol.1998;19:12-17.Accepted for publication November 2, 2001.This article was presented in part at the 107th Congrès Français d'Otorhinolaryngologie et de Pathologie Cervico-faciale, Paris, France, October 1-3, 2000.Corresponding author and reprints: Michel A. Hotz, MD, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Inselspital, 3010 Bern, Switzerland (e-mail: michael.hotz@insel.ch).

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Jun 1, 2002

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month